SIRT1 and adenocarcinoma: Early studies using the TRAMP mouse model showed stable SIRT1 expression during early carcinogenesis but a significant increase in poorly differentiated adenocarcinomas, correlating with reduced levels of hypermethylated in cancer-1 (HIC1), a regulator of SIRT1 [99].